MENUMENU
  • About Us
    • Statement From CEO
    • Our Leadership
    • Partnerships
  • Programs
    • Cancer Immunotherapy
    • Retinal Degeneration
    • Skincare
  • News & Media
  • Contact Us
MENUMENU
  • About Us
    • Statement From CEO
    • Our Leadership
    • Partnerships
  • Programs
    • Cancer Immunotherapy
    • Retinal Degeneration
    • Skincare
  • News & Media
  • Contact Us
  •  
  • June 2017

AIVITA Comments on Positive Findings from Asterias’ SCiStar Trial for Spinal Cord Injury

AIVITA Biomedical CEO Hans Keirstead, Ph.D. to Speak at Stem Cell Cures Consortium Conference

AIVITA Biomedical is an Irvine, CA based company focused on the advancement of commercial and clinical-stage programs utilizing curative and regenerative medicines. We leverage our unique expertise in stem cell growth and directed, high-purity differentiation to develop safe, efficient and economical manufacturing processes for therapeutic development.

Recent News

  • AIVITA Biomedical Announces Publication Comparing Clinical Outcomes in Patients Treated with AIVITA’s Immunotherapy and Other Immunotherapies
  • ROOT OF SKIN™ Skincare Products Sell Out in Tenth Consecutive Appearance on QVC Japan
  • AIVITA Biomedical Announces Publication Concerning a Predictive Biomarker for Melanoma Patients Treated with the Company’s Platform Immunotherapy
  • AIVITA CEO Dr. Hans Keirstead Honored as One of Canada’s ‘Seven Wonderers’ at Beakerhead Festival
  • AIVITA Biomedical to Present at Meeting on the Mesa and Other Investor, Oncology and Regenerative Medicine Conferences in October

Site Navigation

  • About Us
  • Programs
  • News & Media
  • Contact Us
Copyright © 2017 | AIVITA Biomedical